Vornorexant
Vornorexant (ORN-0829; TS-142) is a potent dual OX1R and OX2R antagonist with IC50 values of 1.05 nM and 1.27 nM, respectively. Vornorexant exhibits potent sleep-promoting effects in vivo and can be used for insomnia research research.
Product Specifications
CAS Number
1517965-94-4
Product Name Alternative
ORN-0829; TS-142
UNSPSC
12352005
Target
Orexin Receptor (OX Receptor)
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/vornorexant.html
Purity
98.16
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(N1[C@@H](OCCC1)CN2N=C(C3=CC=C(C=N3)F)C=C2)C4=C(N5N=CC=N5)C=CC(C)=C4
Molecular Formula
C23H22FN7O2
Molecular Weight
447.46
References & Citations
[1]Aya Futamura, et al. Discovery of ORN0829, a potent dual orexin 1/2 receptor antagonist for the treatment of insomnia. Bioorg Med Chem. 2020 Jul 1;28 (13) :115489.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
OX2 Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP325657L 1 mg
alpha 1 Antitrypsin (SERPINA1) (NM_001127702) Human Recombinant Protein
Sign In for Pricing
View Details 
BNC882117-500 1x 500 µL
ARF1 (Golgi Apparatus Marker) (ARF1/2117), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
